| Child group (< 18 years) | Adult group (≥ 18 years) | P value* |
---|---|---|---|
Numbers of patients | 74 | 16 | Â |
Age (years) | 10.7 (IQR 7.5 ~ 14) | 26.7 (IQR 19 ~ 31) |  |
Male % | 60.8% (45 out of 74) | 62.5% (10 out of 16) | 1.0 |
Sillence subtypes | Â | Â | 0.015 |
 I | n = 7a (11.1%) b | n = 1 (6.7%) |  |
 III | n = 8 (12.7%) | n = 7 (46.7%) |  |
 IV | n = 40 (63.5%) | n = 6 (40%) |  |
 V | n = 8 (12.7%) | n = 1 (6.7%) |  |
Number of fractures per year | 1.1 (IQR 0.6 ~ 1.4) | 0.5 (IQR 0.2 ~ 0.5) | 0.003 |
Leg length discrepancy (LLD) | 61.8% (42 out of 68) | 92.8% (13 out of 14) | 0.052 |
Dentinogenesis imperfecta | 58.4% (38 out of 65) | 50% (7 out of 14) | 0.78 |
Limited joint mobility | 22.4% (15 out of 67) | 42.8% (6 out of 14) | 0.21 |
Hearing loss | 5.9% (4 out of 68) | 7.1% (1 out of 14) | 1.0 |
Scoliosis | 47.8% (32 out of 67) | 73.3% (11 out of 15) | 0.13 |
Radial head dislocation | 18.2 (12 out of 66) | 28.6% (4 out of 14) | 0.61 |
Sclera | 73.1% (49 out of 67) | 71.4% (10 out of 14) | 1.0 |
Muscle strengthsc | 4.0 (IQR 3.7 ~ 4.3) | 3.6 (IQR 3.3 ~ 4.0) | 0.19 |
 2 | n = 3a | n = 0 |  |
 2+ | n = 1 | n = 0 |  |
 3 | n = 6 | n = 1 |  |
 3+ | n = 7 | n = 1 |  |
 4− | n = 1 | n = 0 |  |
 4 | n = 19 | n = 2 |  |
 4+ | n = 4 | n = 2 |  |
 5 | n = 2 | n = 1 |  |